COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

Title
COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CANCER
Volume 132, Issue -, Pages 122-124
Publisher
Elsevier BV
Online
2020-04-23
DOI
10.1016/j.ejca.2020.04.004

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started